Why the study?
Does the neutrophil to lymphocyte ratio (NLR) predict severity and prognosis in heart failure patients?
Does the neutrophil to lymphocyte ratio (NLR) predict severity and prognosis in heart failure patients?
Increased neutrophil to lymphocyte ratio is a valuable biomarker for assessing severity and poor prognosis in heart failure.
May support adjunctive NLR use in HF risk assessment; leaves open incremental value over standard markers in prospective studies.
Increased NLR in HF patients can be a valuable auxiliary biomarker of severity, and most of all, of poor prognosis.
No takes yet. Share an insight, caveat, or question.
Delcea et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: